No. enhanced tumor regression, restorative response rate, and T cellCmediated antitumor immunity. Notably, the chimeric Arbidol antigen receptor T cells derived from clone #4 significantly inhibited TNBC cell viability and tumor growth EphA10 mAbs and EphA10-specific chimeric antigen receptorCT cell therapy may represent a encouraging strategy for individuals with EphA10-positive tumors. Keywords: ephrin receptor A10, […]